AAO Meeting: More than 15.000 ophthalmologists meet in Chicago
The annual congress of the American Academy for Ophthalmology (AAO) 2014 is scheduled for October 17-21 in Chicago. The ifa team presents the new IMS software generation (IMS = ICD-10, Meaningful Use, SNOMED) together with training sessions for established and new users. The version 7.x (IMS version) is full MU 2014 compatible and already implements the complete ICD-10 transition functionality in the US. An integral part of the new SW generation is the Clinical Coding Management Module (CCMM) which is an exclusive development by the ifa software engineering team based on the experience of 20+ years with ICD-10 in most countries worldwide. Chris Reinartz, Chief Technology Officer: “We are definitely proud of the new software generation and the corresponding certification. With IMS we enter a new era of Health IT with complex data communication between physicians who manage the same patients. The innovative platform is also designed for a comprehensive clinical decision support (CDS) which is also part of the official approval by the US government.”
ESCRS London: Great success for the international ifa Team
The annual ESCRS (European Society for Cataract and Refractive Surgery) meeting in London was the most successful exhibition for the ifa team in Europe so far. Robert Habel, VP Sales International: Within the five exhibition days we registered twice the number of visitors compared with standard meetings in Europe.
Always profitable investments: ifa software and ifa stocks
The ifa group of companies is the international market leader for Health IT for ophthalmologists. Investments in Electronic Medical Records (EMR) can guarantee a high ROI (Return on Investment). And also on the financial market ifa can offer attractive investments. As the only vendor for ophthalmic specific software ifa offers the advantages of a public company. The financials are transparent for due diligence processes and represent a robust foundation for the future developments. The ifa stocks are listed at the Frankfurt Stock Exchange/Entry Standard (symbol IS8/WKN783078) and at the OTC Market in New York (symbol FYSSY/ISIN US44951T1034). For comprehensive business information about the ifa systems AG the Edison Group London offers a detailed research study with up to date data (Link Edison Group Research on ifa).
Information for Investors
The shareholder conference of the ifa systems AG (IS8) is scheduled for July 3, 2014 (Pullmann Hotel, Cologne). The dividend for 2013 will be proposed with 0,09 Euro (2012: 0,03 Euro). For the Company Report 2013 (English translation) please click here.
Knowledge and software can improve healthcare
The ifa team presented the latest development for clinical decision support (CDS) at the ASCRS (American Society for Cataract and Refractive Surgery) meeting in Boston. The “Clinical Coding Management Module” (CCMM) allows the mapping between different terminology systems and the local clinical language. With standard terminologies such as SNOMED (Systemized Nomenclature in Medicine) and ICD-10 (International Classification of Diseases) physicians can exchange information and use second opinions and improve the communication in co-management networks.
Robert Habel, Director international Key Accounts: “ The CCMM is ideal to implement international bilingual EMR projects. For our new project in Mexico City we use the coding system to map all clinical terms in Spanish and English. That supports the communication of leading international eye institutes and the corresponding exchange of medical knowledge”